These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8819694)

  • 1. Outpatient management of systemic lupus erythematosus.
    Sims GN; Smith HR
    Cleve Clin J Med; 1996; 63(2):94-100. PubMed ID: 8819694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy for systemic lupus erythematosus.
    Taylor JK; McMurray RV
    J Miss State Med Assoc; 2011 Feb; 52(2):39-43. PubMed ID: 21387869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.
    Arnaud L; Mathian A; Boddaert J; Amoura Z
    Drugs Aging; 2012 Mar; 29(3):181-189. PubMed ID: 22263748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus. How to manage, when to refer.
    Dall'Era M; Davis JC
    Postgrad Med; 2003 Nov; 114(5):31-7, 40. PubMed ID: 14650091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus.
    Klein-Gitelman MS; Miller ML
    Indian J Pediatr; 1996; 63(4):485-500. PubMed ID: 10832469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study.
    Bello N; Birt JA; Workman J; Zhou X; Ross-Terres JA; Petri M
    Adv Ther; 2022 Jul; 39(7):3131-3145. PubMed ID: 35534786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus].
    Aringer M; Hiepe F
    Z Rheumatol; 2011 Jun; 70(4):313-23. PubMed ID: 21688092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythmatosus - When to consider and management options.
    Apostolopoulos D; Hoi AY
    Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
    Fujieda Y
    Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic approaches to therapy for systemic lupus erythematosus.
    Xiong W; Lahita RG
    Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
    Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
    Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic lupus erythematosus in children and adolescents].
    Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
    Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus: immunity gone awry.
    Tsokos GC
    Health News; 2002 Aug; 8(8):1-2. PubMed ID: 12206141
    [No Abstract]   [Full Text] [Related]  

  • 20. ANA-negative SLE presenting with nephritis and oculomotor palsy--a case report.
    Sircar S; Taneja VA; Kansra U
    Indian J Pathol Microbiol; 1997 Oct; 40(4):539-42. PubMed ID: 9444868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.